King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia

King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia

RIYADH, Saudi Arabia, May 09, 2024 (GLOBE NEWSWIRE) — Harvard University — Eight years into Vision 2030, Saudi Arabia has made significant strides with digital innovations and enhanced access to quality care. Strategic investments in infrastructure, technology, and talent, have led to advancements revolutionizing patient care delivery and elevating the standards of healthcare locally. These efforts have notably raised the average life expectancy, reduced mortality rates, and enhanced overall well-being across the Kingdom.

Central to these achievements, King Faisal Specialist Hospital & Research Centre (KFSH&RC), renowned for its specialized care and treatments across critical fields such as oncology, cardiology, organ transplantation, and genetics has positioned itself as a leader in specialized patient care, taking the charge towards a brighter, healthier future for the Kingdom. Through its commitment to pioneering digital health initiatives, comprehensive educational programs, and novel research endeavors, it is reshaping the local landscape, and setting new standards of efficiency and accessibility.

In an era defined by technological advancements, and with the Kingdom’s push towards digitalization, KFSH&RC stands at the forefront of digital health integration among its local peers, leveraging cutting-edge telemedicine services, virtual consultations, and AI-driven tools such as the ANFAL AI System that transforms patient outcomes through predictive insights and personalized care, ensuring the best outcomes for patient satisfaction.

KFSH&RC’s digital health initiatives extend to addressing broader health threats through technologies such as Whole Genomic Sequencing (WGS) and Advanced Radiation Therapy. The hospital has also pioneered organ transplantation by performing the world’s first fully robotic liver transplant and introduced to the region innovations like the Harmony Transcatheter Pulmonary Valve (TPV), enhancing patient recovery and experience. These technologies facilitate personalized treatment plans and improve the accuracy and speed of medical diagnostics, contributing significantly to the elevation of patient care standards and a sustainable, resilient healthcare infrastructure in line with the objectives of the Health Sector Transformation Program.

KFSH&RC continues to push the boundaries of medical research addressing pressing health challenges and contributing to Saudi Arabia’s public health landscape, with discoveries like the PfAP2-MRP gene crucial for malaria treatment and the identification of the new Riyadhensis bacteria strain. These discoveries have not only improved diagnostic accuracy but also facilitated early interventions, ensuring timely and effective patient support, in line with the national objectives to reduce chronic disease prevalence.

These comprehensive efforts are supported by KFSH&RC’s robust educational initiatives, which prepare the next generation of medical professionals through training programs and international collaborations.

Recognized by ‘Brand Finance’ in 2024 as the most valuable healthcare brand in Saudi Arabia and the Middle East for the second consecutive year, placing 9th in Saudi Arabia and 28th in the Middle East. Additionally, KFSH&RC stands out as the only hospital worldwide to be ranked among its country’s top ten most valuable brands.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally for the second consecutive year. Additionally, in 2024, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.


For more information, please contact:

Mr. Essam Al-Zahrani, Media Affairs Head, 0555254429

Mr. Abdullah Al-Aown, Media Coordination Officer, 0556294232

A photo accompanying this announcement is available at

Copyright © 2024 GlobeNewswire, Inc.

GlobeNewswire Distribution ID 9114722

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest

Curia & Carterra Biologics Symposium

Biologics symposium slated for May 31 in Seattle, WA

ALBANY, N.Y. and SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization and Carterra Inc., the world leader in label-free high throughput antibody and small molecule drug discovery, today announced their partnership in hosting a high-throughput biologics symposium slated for May 31 at the Residence Inn at Marriott in Seattle, Washington.

The purpose of the collaboration is to promote the rising biotech focus within the Pacific Northwest region of the U.S and Canada. The symposium will bring together all levels of scientific leadership from the biotech and pharma communities.

“We are thrilled to be partnering with Carterra to organize this antibody discovery symposium, bringing the Pacific Northwest biotech community together and sharing the latest advances in antibody discovery,” said Steve Lavezoli, Vice President of Biologics at Curia. “We are also looking forward to sharing our optimal, high-quality and accelerated antibody discovery workflows to first-to-human antibody discovery, development and clinical manufacturing. Antibodies discovered and/or engineered with Curia’s platform technology are in the clinic and we have over 230 successful antibody discovery campaigns performed for the biotech community.”

Speed, scientific expertise and efficiency can surmount the high attrition rates of early antibody discovery and achieve first-to-market delivery of new therapeutics. The symposium will highlight Curia’s technology platform and integrated services with a focus on the development of enhanced mouse systems for antibody generation and high-throughput single B cell screening. The combination of next generation sequencing (NGS) and rapid recombinant production of milligram to gram quantities of purified monoclonal antibody (mAb) significantly accelerates identification of development candidate leads.

Since 2017, Carterra has been selling its powerful LSA® high-throughput biosensor to analyze and characterize antibodies using Surface Plasmon Resonance (SPR). With the launch of its LSAXT platform last year, Carterra now offers products that can perform small molecule analysis as well as antibody discovery. The LSA platform has been profiled in several peer-reviewed papers in Science, Nature and Cell, detailing the path of multiple therapeutics entering clinical trials. At the symposium, several leading scientists in biopharma will be sharing their insights into their specific areas of drug discovery and will highlight the transformative impact of integrating HT-SPR technology, AI/ML and other new technologies.

“We are excited to be partnering with Curia on our symposium. Carterra symposia are scientific events that we host each year throughout the U.S. and Europe,” stated Chris M. Silva, Vice President of Marketing and Product at Carterra. “These symposia help us to share the latest technology advancements and important data generated from the workflows of scientists using Carterra’s label-free platforms. Coming to the Pacific Northwest is an opportunity to create a deeper understanding of the technology in pharma and biotechs in this region.”

Click here to RSVP for the event. Registration is required as seating is limited.

About Curia:
Curia is a Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with Biopharmaceutical customers to bring life-changing therapies to market. Our biologics and small molecules offerings span discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to improve patients’ lives. Visit us at

About Carterra, Inc.:
Carterra, Inc. is a privately held company. Its HT-SPR technology provides large-molecule and small-molecule drug discovery customers with screening and characterization throughput and functionality that scales with omics-level applications, condensing months of work down to days. Our solutions have enabled multiple therapeutics and breakthrough research and helped academic and translational researchers and biopharmaceutical companies in oncology, immunology, neuroscience, and more.  Carterra is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity. To learn more, visit or connect with us on LinkedIn or X (Twitter).

Curia Contact Information:
Viana Bhagan
+1 518 512 2111

Carterra Media Contact:
Cheri Salazar
(408) 594-9400

A photo accompanying this announcement is available at

GlobeNewswire Distribution ID 9114095

Ethiopia, German Reaffirms Commitment to Strengthen Climate Partnership

Addis Ababa: Ethiopia and German have reaffirmed their commitment to advancing climate partnership.

State Minister, Ministry of Planning and Development, Seyoum Mekonnen held discussion with Germany’s State Secretary and Special Envoy for International Climate Action, Jennifer Lee Morgan.

The meeting underscored a mutual dedication to Nationally Determined Contribution (NDC) where renewable energy development and enhancing energy accessibility is key area of intervention.

Ethiopia’s commendable investments in hydropower projects such as GERD and Koisha hydroelectric projects received praise that expected to boost the energy accessibility for Ethiopians.

The Green Legacy Initiative also acknowledged for its significant role for sustainability and effectiveness of the projects to this end, among others, during the meeting.

Germany expressed its keen interest in supporting Ethiopia’s ambitious renewable energy endeavors.

Moreover, the collaboration on NDC and Climate Finance took center stage during discus

The two sides have also exchanged views on Ethiopia’s forthcoming updated Nationally Determined Contribution (NDC 3.0) expected in 2025, with plans outlined for reviewing of the achievements and shortfalls of the existing NDC.

They emphasized the imperative for climate finance accessibility and the capacity to mobilize the resources from the available sources too while innovative financing mechanisms could also be considered. This includes fostering private sector involvement in climate change solutions and green growth.

Germany committed to ongoing support for bolstering stakeholder engagement and capacity building in Ethiopia, particularly in the establishment of a robust climate information/knowledge system emerged as a key priority for collaborative efforts, deemed essential for informed decision-making and effective policy implementation.

The meeting concluded with a resolute commitment from Germany and Ethiopia to intensify collaboration, working closely to accelerate climate action and achie
ve their mutual objectives at national and regional level initiatives.

This strengthened partnership between Germany and Ethiopia signifies a unified resolve to combat climate change and foster a sustainable future for all, according to Ministry of Planning and Development.

Source: Ethiopian News Agency

MoU Providing Multifaceted Health Services for Ex-combatants Signed

Addis Ababa: The National Rehabilitation Commission and Ministry of Health have signed a Memorandum of Understanding (MoU) that enables them to provide multifaceted health services for ex-combatants.

Health State Minister Dr. Ayele Teshome and National Rehabilitation Commissioner Temesgen Tilahun signed the agreement at a training manual validation workshop held today.

The agreement is aimed at making the ex-combatants productive member of the society by providing multifaceted health and related supports, it was learned.

Speaking on the occasion, the state minister said that the challenges combatants encounter during conflicts are multidimensional and demand strong collaboration of all stakeholders.

Various activities, including identifying ex-combatants, their temporal and chronic health problems and psychological and mental related problems will be carried out to address health related problems of the ex-combatants, he added.

According to him, the Ministry of Health, in collaboration with the National
Rehabilitation Commission and other stakeholders, is keen to provide health services for the ex-combatants.

National Rehabilitation Commissioner Temesgen Tilahun stated on his part that health is one of the vital and the primary issues that the commission gives attention to in the rehabilitation and reintegration of the ex-combatants.

Temesgen affirmed that the commission will work closely with the ministry to address all types of health related problems of the ex-combatants.

The commissioner disclosed that the implementation of the agreement will commence as soon as possible as discussions have been carried out during the last one year regarding ways about how to collaborate with the ministry.

At the workshop, the two sides also endorsed a training manual that contains various issues, including psycho-social, health and self-care, among others.

Source: Ethiopian News Agency

Digital Telethon to Raise 50 Mil Birr For Clean Ethiopia in Ten Hours to Be Held on Sunday

Addis Ababa: A ten hours period digital telethon will be launched on the coming Sunday to raise 50 million Birr for Clean Ethiopia campaign initiated by Prime Minister Abiy Ahmed.

It is to be recalled that Prime Minister Abiy Ahmed recently unveiled plans to construct modern, clean and dignified public restrooms, with a strong emphasis on community involvement in their construction.

The initiative, named ‘Clean Ethiopia,’ includes a fundraising component under the theme ‘Clean Cities – Healthy Lives.’

Accordingly, a digital telethon for ‘Clean Ethiopia’ has been officially launched on April 28/2024.

The objective is to solicit both cash and in-kind contributions for the construction of these public facilities.

Office of the Prime Minister disclosed that ‘This Sunday, May 12, 2024, we will launch the 50million Birr in a 10hr period digital telethon challenge for CleanEthiopia.’

Together we can make a meaningful positive impact, the office stated, inviting all to join the challenge for Clean Ethiopia on M
ay 12th.

Source: Ethiopian News Agency

Ethiopia, OHCHR Stress Need to Continue Collaborative Working Relations

Addis Ababa: State Minister of Foreign Affairs of Ethiopia Ambassador Mesganu Arga received today at his office Representative of the Office of the High Commissioner for Human Rights (OHCHR) for the East African Regional Office, Marcel Clement Akpovo.

On the occasion, the commissioner appreciated the support of the Ethiopian government in carrying out his duties.

The State Minister highlighted the government’s various initiatives that helped change the livelihood of many Ethiopians in a number of sectors.

Some of these initiatives are testaments to the government’s commitment to protect the rights of its people, Ambassador Mesganu said.

The two sides noted the need to continue collaborative working relations on human rights issues, according to Foreign Affairs Ministry.

Source: Ethiopian News Agency

Yaounde: Family alleges Doctor delivered deceased daughter through C-section while intoxicated

By Charity Nginyu

A young pregnant woman, Ondoa Elodie, tragically lost her life following a cesarean section performed by a reportedly drunk surgeon at the Afrique Future Hospital Center of Deo Gratias Catholic Hospital in the Emana neighborhood in Yaounde, the family has claimed.

The incident has sparked outrage and legal action, with the family filing a complaint against the hospital for negligence and involuntary manslaughter.

According to reports, Ondoa Elodie visited the hospital to meet with her gynecologist but was unexpectedly admitted. Shortly after that, she underwent a cesarean section performed by a surgeon who was allegedly under the influence of alcohol.

Despite delivering a healthy baby, the family claimed Ondoa Elodie began to hemorrhage profusely after the surgery, with hospital staff failing to intervene effectively.

Tragically, she succumbed to her condition, leaving her newborn daughter motherless.

The family, represented by their legal counsel, Barrister Alexandre Ndengue Ngango, h
as lodged a formal complaint against Deo Gratias Catholic Hospital, accusing them of negligence and manslaughter.

In the complaint, they detailed the sequence of events leading to Ondoa Elodie’s untimely death and highlighted the lack of adequate medical attention provided by the hospital staff.

The complaint alleged that Ondoa Elodie’s post-surgical complications were ignored, ultimately leading to her demise. It also raised questions about the competence and professionalism of the medical personnel involved in her care.

Furthermore, the family’s legal representative has called for a thorough investigation into the incident and accountability for those responsible. They demand justice for Ondoa Elodie and her orphaned daughter.

The administration of the said medical facility is however yet to react to the outburst by the visibly enraged family of the deceased.

Source: Cameroon News Agency